In this regard, an interesting parallel can be drawn with neoplastic cells, as previous studies showed increased susceptibility to the cytotoxic effects of combined Trx and GSH pathway inhibition in lung cancer cells with pharmacologically inhibited glycolysis (Fath et al, 2011; Li et al, 2015). Here, TXN is linked to lung cancer.